Contact
Please use this form to send email to PR contact of this press release:
Oncobiologics Announces Presentation of Final Data from Phase 1 Clinical Study of ONS-3010 (HUMIRA® Biosimilar)
TO:
Please use this form to send email to PR contact of this press release:
Oncobiologics Announces Presentation of Final Data from Phase 1 Clinical Study of ONS-3010 (HUMIRA® Biosimilar)
TO: